A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for slowing Alzheimer’s — a disease with few treatment options.
For years, low carb advocates have claimed that lowering insulin requires cutting carbohydrates. This sounds convincing until ...
In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...
Everyday Health on MSN
Insulin Dos and Don’ts
Master your insulin routine with essential dos and don'ts for safe, effective diabetes management. Learn about proper injection sites, timing, storage, and more.
Objectives This study compared the effectiveness of first-time use of faster aspart with rapid-acting insulin analogues in patients with type 1 diabetes (T1D) or type 2 diabetes (T2D). Design, setting ...
Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...
Utah-based Civica will begin selling a type of long-acting insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility. Civica announced Thursday it has ...
Non inferior HbA1c reduction at 26 weeks (primary endpoint) Significant reduction of the rise of blood glucose after a test meal (key secondary endpoint) Blood glucose level, monitored by 10-point ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results